SCHEMBL6567020

SCHEMBL6567020

COC(=O)c1cc(NC(=O)N(Cc2cccnc2)Cc2cccnc2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 3/20 0.48
HSD17B10 Q99714 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
ALDH1A1 P00352 5/20 0.48
MAPT P10636 2/20 0.48
GAA P10253 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
RECQL P46063 1/20 0.48
CASR P41180 1/20 0.46
HTT P42858 2/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
NAMPT P43490 1/20 0.43
HPGD P15428 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ROCK1 Q13464 1/20 0.42
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566546 0.85 PDE4A (0.48) KDM4EPOLBMAPK1HSD17B10NPSR1
SCHEMBL6565755 0.84 L3MBTL1 (0.63) KDM4EPOLBHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL6566703 0.83 MEN1 (0.50) KDM4EPOLBHSD17B10NPSR1ALDH1A1
SCHEMBL6568097 0.83 CASR (0.54) KDM4EHSD17B10NPSR1ALDH1A1SMN1; SMN2
SCHEMBL6566483 0.83 L3MBTL1 (0.51) KDM4EPOLBHSD17B10ALDH1A1CASR
SCHEMBL6567978 0.83 MEN1 (0.45) KDM4EPOLBMAPK1HSD17B10NPSR1
SCHEMBL6566982 0.82 MTOR (0.47) KDM4EALDH1A1CASRKMT2AMEN1
SCHEMBL6568022 0.81 CASR (0.45) KDM4EHSD17B10NPSR1ALDH1A1MAPT
SCHEMBL6564738 0.80 CASR (0.44) KDM4EPOLBMAPTSMN1; SMN2CASR
SCHEMBL6564496 0.80 CASR (0.50) KDM4EPOLBHSD17B10NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 KDM4E 2962/4885POLB 3499/4885MAPK1 1934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.